Aldeyra Therapeutics, Inc. (ALDX) NASDAQ
1.60
-0.065(-3.92%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.60
-0.065(-3.92%)
Currency In USD
| Market Cap | 311.1M |
| Enterprise Value | 256.58M |
| P/E Ratio | -3.52 |
| PEG Ratio | -0.04 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 1.92M |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0 |
| Return On Equity | -0 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -31.69M |
| Net Income | -33.85M |
| Diluted EPS | -0.56 |
| Total Cash | 65M |
| Total Cash/Share | 1.08M |
| Total Debt | 15.51M |
| Total Debt/Equity | 0.37 |
| Current Ratio | 2.72 |
| Book Value Per Share | 698,897.4 |
| 52-Week Change | -24.76 |
| 52-Week High | 6.18 |
| 52-Week Low | 1.07 |
| Moving Average 50 Days | 1.69 |
| Moving Average 200 Days | 4.23 |
| Average Volume | 3.07M |
| Shares Outstanding | 60.32M |
| % Held by Institutions | 62.02 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |